Jin Tian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jin Tian has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Longmei Tang
School of Public Health, Hebei Medical University, Shijiazhuang, China
5 shared publications - Yongzhao Song
Public Health Department, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, People’s Republic of China
2 shared publications Yuchang Li
2 shared publicationsZhihua Zhang
Hospital Management Innovation Research Center, The First Hospital of Hebei Medical University
2 shared publicationsBaogen Zhao
Department of Radiology and Nuclear Medicine, The First Hospital of Hebei Medical University
1 shared publicationBiao Xi
Medical Education Collaborative Innovation Center, Hebei Medical University
1 shared publication
Latest Publications
- Open Access
- 17 September 2026
- Published by Springer Nature in BMC Medical Education
Evaluating the conditions for practice-based learning: an expert-informed Input–Process–Output framework for Master of Public Health programmes in China
Background: Preparing Master of Public Health (MPH) graduates for practice requires opportunities to apply evidence to population-health problems and receive feedback on their work. This study developed an expert-informed Input–Process–Output (IPO) framework for evaluating how Chinese MPH programmes organise practical training, supervision and assessment within the wider programme. Methods: Policy and institutional documents, published research and interviews with 20 public health professionals in Hebei Province informed 49 candidate indicators. Two Delphi rounds, involving 20 and 18 experts, assessed importance, scientific soundness and feasibility. Item ratings were summarised descriptively, and tie-corrected Kendall’s W assessed concordance in relative rankings. Fuzzy analytic hierarchy weighting used the first author’s pairwise judgements, with calculations jointly checked by the first and corresponding authors. Products of local weights were normalised to obtain global indicator weights. Results: The final framework comprised three primary dimensions, nine secondary domains, 19 tertiary subdomains and 45 fourth-level indicators. Round 2 mean ratings ranged from 3.89 to 4.67 across the three rating dimensions, with all coefficients of variation ≤ 0.25. Rank concordance was low: Kendall’s W was 0.0529 for importance, 0.0569 for scientific soundness and 0.0474 for feasibility (all P > 0.05). Process received the highest primary weight (0.481), followed by Input (0.266) and Output (0.253). Specification of practice-mentor guidance time had the highest normalised global weight (0.080508), followed by dual-qualified faculty and four equally weighted indicators concerning practical training and assessment. Conclusions: The framework identifies candidate conditions for practice-based MPH learning and offers a structure for reviewing practical training, supervision and assessment. Empirical evaluation is needed to determine whether these arrangements are implemented as intended and associated with students’ public health performance.
- 17 September 2026
- Published by Springer Nature in BMC Medical Education
Open AccessEvaluating the conditions for practice-based learning: an expert-informed Input–Process–Output framework for Master of Public Health programmes in China
Background: Preparing Master of Public Health (MPH) graduates for practice requires opportunities to apply evidence to population-health problems and receive feedback on their work. This study developed an expert-informed Input–Process–Output (IPO) framework for evaluating how Chinese MPH programmes organise practical training, supervision and assessment within the wider programme. Methods: Policy and institutional documents, published research and interviews with 20 public health professionals in Hebei Province informed 49 candidate indicators. Two Delphi rounds, involving 20 and 18 experts, assessed importance, scientific soundness and feasibility. Item ratings were summarised descriptively, and tie-corrected Kendall’s W assessed concordance in relative rankings. Fuzzy analytic hierarchy weighting used the first author’s pairwise judgements, with calculations jointly checked by the first and corresponding authors. Products of local weights were normalised to obtain global indicator weights. Results: The final framework comprised three primary dimensions, nine secondary domains, 19 tertiary subdomains and 45 fourth-level indicators. Round 2 mean ratings ranged from 3.89 to 4.67 across the three rating dimensions, with all coefficients of variation ≤ 0.25. Rank concordance was low: Kendall’s W was 0.0529 for importance, 0.0569 for scientific soundness and 0.0474 for feasibility (all P > 0.05). Process received the highest primary weight (0.481), followed by Input (0.266) and Output (0.253). Specification of practice-mentor guidance time had the highest normalised global weight (0.080508), followed by dual-qualified faculty and four equally weighted indicators concerning practical training and assessment. Conclusions: The framework identifies candidate conditions for practice-based MPH learning and offers a structure for reviewing practical training, supervision and assessment. Empirical evaluation is needed to determine whether these arrangements are implemented as intended and associated with students’ public health performance.
- Open Access
- 8 July 2026
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 14, 1871195
Vitamin D deficiency among apparently healthy adults in northern China: behavioral correlates and an indoor-lifestyle framework
Background/objectives: Vitamin D deficiency is not confined to traditionally defined high-risk groups, yet its prevalence and modifiable behavioral correlates among apparently healthy adults remain poorly characterized, particularly in northern China. This study assessed vitamin D status among adults undergoing routine health examinations in Hebei Province and examined whether modifiable behavioral factors were independently associated with deficiency risk. Methods: A cross-sectional study was conducted among 4,811 adults attending routine health examinations in Hebei Province, China, after exclusion of participants with documented major chronic conditions known to affect vitamin D metabolism. Serum 25-hydroxyvitamin D [25(OH)D] was measured, and vitamin D deficiency was defined as <20 ng/mL. Structured questionnaires were used to collect information on sunlight exposure, physical activity, dietary vitamin D intake, and vitamin D-containing supplement use. Multivariable logistic regression models were applied to examine associations between these behavioral factors and vitamin D deficiency, with adjustment for sex, age group, smoking status, alcohol consumption, BMI category, and season of blood collection. A cumulative behavioral score was constructed to assess the combined association of favorable behavioral factors with deficiency risk. Results: The median serum 25(OH)D concentration was 20.5 ng/mL (IQR 15.4–26.6), and 47.5% of participants were vitamin D deficient, while only 15.3% had sufficient vitamin D status. Deficiency was more prevalent in women, younger and working-age adults, and participants examined during winter. In the fully adjusted model, sunlight exposure ≥30 min/day (OR 0.677, 95% CI 0.599–0.765), moderate-to-high physical activity (OR 0.773, 95% CI 0.678–0.880), adequate dietary vitamin D intake (OR 0.734, 95% CI 0.651–0.828), and vitamin D supplementation (OR 0.797, 95% CI 0.705–0.902) were each associated with lower odds of deficiency. A graded inverse association was observed for the cumulative behavioral score; compared with participants with no favorable behavioral factors, those with four had substantially lower odds of deficiency (OR 0.285, 95% CI 0.189–0.423). Conclusion: Vitamin D deficiency was highly prevalent among adults attending routine health examinations in northern China after exclusion of major chronic conditions known to affect vitamin D metabolism. The burden was concentrated in women, younger and working-age adults, and winter months, while lower deficiency risk was consistently associated with more favorable behavioral patterns. The observed distribution is consistent with an indoor-lifestyle framework in which vitamin D status is shaped not only by the environmental availability of sunlight, but also by the extent to which daily routines permit effective ultraviolet exposure.
- 8 July 2026
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 14, 1871195
Open AccessVitamin D deficiency among apparently healthy adults in northern China: behavioral correlates and an indoor-lifestyle framework
Background/objectives: Vitamin D deficiency is not confined to traditionally defined high-risk groups, yet its prevalence and modifiable behavioral correlates among apparently healthy adults remain poorly characterized, particularly in northern China. This study assessed vitamin D status among adults undergoing routine health examinations in Hebei Province and examined whether modifiable behavioral factors were independently associated with deficiency risk. Methods: A cross-sectional study was conducted among 4,811 adults attending routine health examinations in Hebei Province, China, after exclusion of participants with documented major chronic conditions known to affect vitamin D metabolism. Serum 25-hydroxyvitamin D [25(OH)D] was measured, and vitamin D deficiency was defined as <20 ng/mL. Structured questionnaires were used to collect information on sunlight exposure, physical activity, dietary vitamin D intake, and vitamin D-containing supplement use. Multivariable logistic regression models were applied to examine associations between these behavioral factors and vitamin D deficiency, with adjustment for sex, age group, smoking status, alcohol consumption, BMI category, and season of blood collection. A cumulative behavioral score was constructed to assess the combined association of favorable behavioral factors with deficiency risk. Results: The median serum 25(OH)D concentration was 20.5 ng/mL (IQR 15.4–26.6), and 47.5% of participants were vitamin D deficient, while only 15.3% had sufficient vitamin D status. Deficiency was more prevalent in women, younger and working-age adults, and participants examined during winter. In the fully adjusted model, sunlight exposure ≥30 min/day (OR 0.677, 95% CI 0.599–0.765), moderate-to-high physical activity (OR 0.773, 95% CI 0.678–0.880), adequate dietary vitamin D intake (OR 0.734, 95% CI 0.651–0.828), and vitamin D supplementation (OR 0.797, 95% CI 0.705–0.902) were each associated with lower odds of deficiency. A graded inverse association was observed for the cumulative behavioral score; compared with participants with no favorable behavioral factors, those with four had substantially lower odds of deficiency (OR 0.285, 95% CI 0.189–0.423). Conclusion: Vitamin D deficiency was highly prevalent among adults attending routine health examinations in northern China after exclusion of major chronic conditions known to affect vitamin D metabolism. The burden was concentrated in women, younger and working-age adults, and winter months, while lower deficiency risk was consistently associated with more favorable behavioral patterns. The observed distribution is consistent with an indoor-lifestyle framework in which vitamin D status is shaped not only by the environmental availability of sunlight, but also by the extent to which daily routines permit effective ultraviolet exposure.
- Open Access
- 2 July 2026
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 14, 1817328
Rebalancing health investment across the life course: a high-value age segments framework for aging societies
Health systems in rapidly aging societies continue to direct a disproportionate share of expenditure toward reactive, late-life care, despite evidence that earlier and mid-life investment can generate substantial long-term population health returns. High-Value Age Segments (HVAS) are proposed as a life-course framework for prioritizing health investment according to differences in marginal returns across age groups. Three broad periods are identified: early life from the fetal stage to approximately age 25, mid-adulthood from ages 26 to 55, and later adulthood from age 56 onward. Early-life interventions are associated with durable gains in health and human development, mid-adulthood interventions with delayed chronic disease onset and preserved productivity, and later-life interventions with reduced morbidity and maintenance of functional capacity. Embedding HVAS within policy frameworks may support more efficient and sustainable allocation of health resources under demographic aging.
- 2 July 2026
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 14, 1817328
Open AccessRebalancing health investment across the life course: a high-value age segments framework for aging societies
Health systems in rapidly aging societies continue to direct a disproportionate share of expenditure toward reactive, late-life care, despite evidence that earlier and mid-life investment can generate substantial long-term population health returns. High-Value Age Segments (HVAS) are proposed as a life-course framework for prioritizing health investment according to differences in marginal returns across age groups. Three broad periods are identified: early life from the fetal stage to approximately age 25, mid-adulthood from ages 26 to 55, and later adulthood from age 56 onward. Early-life interventions are associated with durable gains in health and human development, mid-adulthood interventions with delayed chronic disease onset and preserved productivity, and later-life interventions with reduced morbidity and maintenance of functional capacity. Embedding HVAS within policy frameworks may support more efficient and sustainable allocation of health resources under demographic aging.
- Top Cited PapersOpen Access
- 1 June 2026
- Published by Taylor & Francis in Risk Management and Healthcare Policy
- Vol. ume 19, 1-11
Clinical Artificial Intelligence Implementation in Routine Care: Real-World Operational Outcomes from a Provincial Health System in China
Background: Clinical artificial intelligence (AI) technologies are increasingly being introduced into hospital practice, yet evidence describing their operational integration and performance after deployment in routine clinical settings remains limited. This study examined the real-world implementation and operational integration of clinical AI within a provincial tertiary health system in China over an 18-month observation period. Methods: This retrospective longitudinal observational study used aggregated institutional data generated during routine platform deployment, including electronic medical record–linked system logs, deployment records, quality-monitoring summaries, and operational reports. The analysis focused on implementation patterns, workflow integration, selected operational indicators, and user acceptance during routine clinical use. The study evaluated implementation and operational integration rather than algorithmic accuracy, diagnostic performance, or patient-level clinical effectiveness. Results: Three AI-supported clinical pathways were included: an intelligent pre-consultation system, a multidisciplinary tumor decision-support system, and a duloxetine therapeutic drug-monitoring pathway. During the observation period, 127 clinicians across 53 specialties participated in AI-assisted clinical activities involving more than 27,000 patient encounters, 850 multidisciplinary tumor decision-support cases, and 320 therapeutic drug-monitoring episodes. Patient waiting time decreased from 18 to 13 minutes, patient satisfaction increased from 95.40% to 98.92%, consultation efficiency improved by approximately 40%, and documentation completion efficiency improved by approximately 80%. Implementation patterns differed substantially across pathways, reflecting differences in workflow position and clinical accountability rather than deployment effort alone. Conclusion: In this provincial tertiary health system, clinical AI implementation was associated with sustained operational use, cross-specialty workflow integration, and measurable changes in selected workflow indicators. These findings suggest that technical functionality alone is insufficient for sustained clinical AI use and that workflow compatibility and organizational readiness are central to routine implementation. Because this was a single-site observational study using aggregated operational data, the findings should be interpreted as implementation evidence rather than proof of clinical effectiveness. Plain Language Summary: Many hospital AI systems are tested in pilot settings but are not subsequently integrated into routine clinical operations. This study examined how a clinical AI platform was deployed in routine care at a large teaching hospital in Hebei Province, China, over an 18-month period. The study used routine hospital data, including electronic medical record–linked system logs, deployment records, quality-monitoring summaries, operational reports, and patient satisfaction information. No identifiable patient information was accessed. The analysis examined how widely the AI tools were used, which clinical services adopted them, and whether selected workflow indicators changed following routine deployment. Three AI-supported tools were included: an intelligent pre-consultation system, a multidisciplinary tumor decision-support system, and a duloxetine therapeutic drug-monitoring system. In total, 127 clinicians across 53 specialties used the platform, involving more than 27,000 patient encounters, 850 tumor decision-support cases, and 320 drug-monitoring episodes. Patient waiting time decreased from 18 to 13 minutes, patient satisfaction increased from 95.40% to 98.92%, consultation efficiency improved by approximately 40%, and documentation efficiency improved by approximately 80%. The findings suggest that clinical AI can move from pilot use into routine hospital workflows when deployment is grounded in existing clinical workflows and backed by sustained organizational support. Because this was an observational study from a single hospital, the findings should be interpreted cautiously and confirmed in other settings.
- 1 June 2026
- Published by Taylor & Francis in Risk Management and Healthcare Policy
- Vol. ume 19, 1-11
Top Cited PapersOpen AccessClinical Artificial Intelligence Implementation in Routine Care: Real-World Operational Outcomes from a Provincial Health System in China
Background: Clinical artificial intelligence (AI) technologies are increasingly being introduced into hospital practice, yet evidence describing their operational integration and performance after deployment in routine clinical settings remains limited. This study examined the real-world implementation and operational integration of clinical AI within a provincial tertiary health system in China over an 18-month observation period. Methods: This retrospective longitudinal observational study used aggregated institutional data generated during routine platform deployment, including electronic medical record–linked system logs, deployment records, quality-monitoring summaries, and operational reports. The analysis focused on implementation patterns, workflow integration, selected operational indicators, and user acceptance during routine clinical use. The study evaluated implementation and operational integration rather than algorithmic accuracy, diagnostic performance, or patient-level clinical effectiveness. Results: Three AI-supported clinical pathways were included: an intelligent pre-consultation system, a multidisciplinary tumor decision-support system, and a duloxetine therapeutic drug-monitoring pathway. During the observation period, 127 clinicians across 53 specialties participated in AI-assisted clinical activities involving more than 27,000 patient encounters, 850 multidisciplinary tumor decision-support cases, and 320 therapeutic drug-monitoring episodes. Patient waiting time decreased from 18 to 13 minutes, patient satisfaction increased from 95.40% to 98.92%, consultation efficiency improved by approximately 40%, and documentation completion efficiency improved by approximately 80%. Implementation patterns differed substantially across pathways, reflecting differences in workflow position and clinical accountability rather than deployment effort alone. Conclusion: In this provincial tertiary health system, clinical AI implementation was associated with sustained operational use, cross-specialty workflow integration, and measurable changes in selected workflow indicators. These findings suggest that technical functionality alone is insufficient for sustained clinical AI use and that workflow compatibility and organizational readiness are central to routine implementation. Because this was a single-site observational study using aggregated operational data, the findings should be interpreted as implementation evidence rather than proof of clinical effectiveness. Plain Language Summary: Many hospital AI systems are tested in pilot settings but are not subsequently integrated into routine clinical operations. This study examined how a clinical AI platform was deployed in routine care at a large teaching hospital in Hebei Province, China, over an 18-month period. The study used routine hospital data, including electronic medical record–linked system logs, deployment records, quality-monitoring summaries, operational reports, and patient satisfaction information. No identifiable patient information was accessed. The analysis examined how widely the AI tools were used, which clinical services adopted them, and whether selected workflow indicators changed following routine deployment. Three AI-supported tools were included: an intelligent pre-consultation system, a multidisciplinary tumor decision-support system, and a duloxetine therapeutic drug-monitoring system. In total, 127 clinicians across 53 specialties used the platform, involving more than 27,000 patient encounters, 850 tumor decision-support cases, and 320 drug-monitoring episodes. Patient waiting time decreased from 18 to 13 minutes, patient satisfaction increased from 95.40% to 98.92%, consultation efficiency improved by approximately 40%, and documentation efficiency improved by approximately 80%. The findings suggest that clinical AI can move from pilot use into routine hospital workflows when deployment is grounded in existing clinical workflows and backed by sustained organizational support. Because this was an observational study from a single hospital, the findings should be interpreted cautiously and confirmed in other settings.
- Open Access
- 29 May 2026
- Vol. 16, 03014
When health systems invest matters: temporal imbalance and the case for life-course reorientation.
Health systems worldwide face growing pressure from population ageing and the rising burden of noncommunicable diseases. Yet policy debates still focus mainly on how much is spent, while paying much less attention to when health systems invest. In many settings, spending remains concentrated in late-stage curative care, whereas earlier phases of the life course, when risks are still developing and remain modifiable, receive less sustained investment. We describe this mismatch as a temporal imbalance: a misalignment between when health risks accumulate and when resources are allocated. We argue that the pattern persists because institutions are usually rewarded for responding to visible burden, while the returns to earlier intervention are delayed, diffuse, and harder to attribute. As a result, organisations that invest early often cannot readily claim the later benefits of doing so. This creates a temporal accountability gap. Drawing on life-course epidemiology, health financing research, clinical perspectives from endocrinology and palliative care, and illustrative expenditure data from Hebei Province, China, we examine timing as an overlooked dimension of health policy and propose three practical policy actions: routine life-course expenditure reporting, longer evaluation horizons for prevention, and financing mechanisms that reward earlier investment.
- 29 May 2026
- Vol. 16, 03014
Open AccessWhen health systems invest matters: temporal imbalance and the case for life-course reorientation.
Health systems worldwide face growing pressure from population ageing and the rising burden of noncommunicable diseases. Yet policy debates still focus mainly on how much is spent, while paying much less attention to when health systems invest. In many settings, spending remains concentrated in late-stage curative care, whereas earlier phases of the life course, when risks are still developing and remain modifiable, receive less sustained investment. We describe this mismatch as a temporal imbalance: a misalignment between when health risks accumulate and when resources are allocated. We argue that the pattern persists because institutions are usually rewarded for responding to visible burden, while the returns to earlier intervention are delayed, diffuse, and harder to attribute. As a result, organisations that invest early often cannot readily claim the later benefits of doing so. This creates a temporal accountability gap. Drawing on life-course epidemiology, health financing research, clinical perspectives from endocrinology and palliative care, and illustrative expenditure data from Hebei Province, China, we examine timing as an overlooked dimension of health policy and propose three practical policy actions: routine life-course expenditure reporting, longer evaluation horizons for prevention, and financing mechanisms that reward earlier investment.
- Top Cited PapersOpen Access
- 7 May 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28 (1) , e92680
From Pilot Trap to Institutional Capacity: A Governance Framework for Sustainable Clinical AI Implementation in Health Systems
Clinical artificial intelligence (AI) applications frequently fail to transition from short-term pilot projects into sustained components of routine clinical care, a phenomenon referred to in this viewpoint as the pilot trap. This persistent gap reflects not only technical or regulatory limitations but also insufficient governance capacity within health care organizations. We argue that such capacity is not fully established before deployment; rather, it develops through implementation as real-world operational tensions clarify organizational ownership, accountability boundaries, and coordination mechanisms. Drawing on an 18-month implementation of a provincial clinical AI platform in China, we develop a 6-module governance framework encompassing institutional carrier formation, infrastructure governance, regulatory and ethical governance, interdisciplinary coordination, translational scaling, and lifecycle evaluation and oversight. These modules represent functional governance conditions observed during implementation rather than a prescriptive institutional architecture to be installed prior to deployment. We further introduce the concept of functional transferability and position the framework as an upstream complement to existing international governance standards, which typically specify what governance should achieve, but often assume that the organizational capacity to implement it already exists. Advancing clinical AI beyond demonstration, therefore, depends less on model performance alone than on the ability of health systems to develop and sustain the institutional capacity required for routine clinical use.
- 7 May 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28 (1) , e92680
Top Cited PapersOpen AccessFrom Pilot Trap to Institutional Capacity: A Governance Framework for Sustainable Clinical AI Implementation in Health Systems
Clinical artificial intelligence (AI) applications frequently fail to transition from short-term pilot projects into sustained components of routine clinical care, a phenomenon referred to in this viewpoint as the pilot trap. This persistent gap reflects not only technical or regulatory limitations but also insufficient governance capacity within health care organizations. We argue that such capacity is not fully established before deployment; rather, it develops through implementation as real-world operational tensions clarify organizational ownership, accountability boundaries, and coordination mechanisms. Drawing on an 18-month implementation of a provincial clinical AI platform in China, we develop a 6-module governance framework encompassing institutional carrier formation, infrastructure governance, regulatory and ethical governance, interdisciplinary coordination, translational scaling, and lifecycle evaluation and oversight. These modules represent functional governance conditions observed during implementation rather than a prescriptive institutional architecture to be installed prior to deployment. We further introduce the concept of functional transferability and position the framework as an upstream complement to existing international governance standards, which typically specify what governance should achieve, but often assume that the organizational capacity to implement it already exists. Advancing clinical AI beyond demonstration, therefore, depends less on model performance alone than on the ability of health systems to develop and sustain the institutional capacity required for routine clinical use.
- Open Access
- 2 February 2026
- Published by JMIR Publications Inc. in JMIR Preprints
From Pilot Trap to Infrastructure: A Governance Framework for Clinical AI Institutionalization in Health Systems (Preprint)
BACKGROUND Despite increasing technical maturity, most clinical artificial intelligence (AI) systems remain confined to pilot or experimental settings, rarely achieving sustained integration into routine healthcare delivery. The persistence of this "pilot trap" is driven primarily by structural and institutional constraints rather than algorithmic performance limitations. OBJECTIVE To develop a governance framework that enables the transition of clinical artificial intelligence (AI) from project-based experimentation to durable institutional infrastructure, informed by the establishment of a provincial-level AI platform within a policy-oriented healthcare system in China. METHODS An 18-month real-world institutionalization process of the Hebei Provincial Clinical AI Platform was examined, encompassing the formation of a dedicated Medical AI laboratory, designation as a provincial engineering center, acquisition of regulatory authorizations, and deployment of structured clinical application pathways. Framework construction was grounded in systematic analysis of governance arrangements, policy legitimacy mechanisms, and translational implementation trajectories observed throughout the institutionalization process. RESULTS The framework comprises six interdependent modules encompassing institutional carrier formation, data and computational infrastructure, ethical and regulatory governance, interdisciplinary operational coordination, translational scaling and regional dissemination, and continuous evaluation. Implementation evidence indicates that governance architecture functions as a prerequisite to, rather than a consequence of, technical deployment. Organizational anchoring, external legitimacy, and coordinating capacity enable AI systems to operate as enduring institutional infrastructure rather than transient technological experiments. The framework reframes clinical AI from an algorithmic artifact to an embedded institutional capability, redirecting implementation logic from technical performance metrics toward governance maturity. CONCLUSIONS Sustainable clinical AI implementation is associated with governance-first rather than technology-first strategies. Effective institutionalization requires the concurrent establishment of organizational ownership, policy legitimacy, and coordinating mechanisms prior to large-scale deployment. Although derived from a policy-oriented healthcare context in China, the core governance functions demonstrate potential transferability across health systems, with institutional mechanisms varying by context while functional requirements remain comparatively stable. The framework offers an operational architecture for health systems seeking AI as infrastructure rather than episodic experimentation. CLINICALTRIAL NA.
- 2 February 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessFrom Pilot Trap to Infrastructure: A Governance Framework for Clinical AI Institutionalization in Health Systems (Preprint)
BACKGROUND Despite increasing technical maturity, most clinical artificial intelligence (AI) systems remain confined to pilot or experimental settings, rarely achieving sustained integration into routine healthcare delivery. The persistence of this "pilot trap" is driven primarily by structural and institutional constraints rather than algorithmic performance limitations. OBJECTIVE To develop a governance framework that enables the transition of clinical artificial intelligence (AI) from project-based experimentation to durable institutional infrastructure, informed by the establishment of a provincial-level AI platform within a policy-oriented healthcare system in China. METHODS An 18-month real-world institutionalization process of the Hebei Provincial Clinical AI Platform was examined, encompassing the formation of a dedicated Medical AI laboratory, designation as a provincial engineering center, acquisition of regulatory authorizations, and deployment of structured clinical application pathways. Framework construction was grounded in systematic analysis of governance arrangements, policy legitimacy mechanisms, and translational implementation trajectories observed throughout the institutionalization process. RESULTS The framework comprises six interdependent modules encompassing institutional carrier formation, data and computational infrastructure, ethical and regulatory governance, interdisciplinary operational coordination, translational scaling and regional dissemination, and continuous evaluation. Implementation evidence indicates that governance architecture functions as a prerequisite to, rather than a consequence of, technical deployment. Organizational anchoring, external legitimacy, and coordinating capacity enable AI systems to operate as enduring institutional infrastructure rather than transient technological experiments. The framework reframes clinical AI from an algorithmic artifact to an embedded institutional capability, redirecting implementation logic from technical performance metrics toward governance maturity. CONCLUSIONS Sustainable clinical AI implementation is associated with governance-first rather than technology-first strategies. Effective institutionalization requires the concurrent establishment of organizational ownership, policy legitimacy, and coordinating mechanisms prior to large-scale deployment. Although derived from a policy-oriented healthcare context in China, the core governance functions demonstrate potential transferability across health systems, with institutional mechanisms varying by context while functional requirements remain comparatively stable. The framework offers an operational architecture for health systems seeking AI as infrastructure rather than episodic experimentation. CLINICALTRIAL NA.
- 18 August 2025
- Published by Taylor & Francis in International Journal of Healthcare Management
- Vol. 19 (4) , 1-18
Hospital furniture design: Cultural evolution and future trends
- 18 August 2025
- Published by Taylor & Francis in International Journal of Healthcare Management
- Vol. 19 (4) , 1-18
Hospital furniture design: Cultural evolution and future trends
- Open Access
- 1 October 2021
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in Acta bioethica
- Vol. 27 (2) , 193-200
Palliative care for Chinese immigrants in New Zealand: experiences and perceptions
Over the past several decades, palliative care has seen tremendous development in Western countries, but there is still inadequate access to palliative care among non-dominant ethnocultural groups. The Chinese have been the largest immigrant group in New Zealand since the 19th century(1). They have unique beliefs and practices around illness, death, dying and filial piety(2). These differ greatly from those in Western cultures and have notable implications for hospice palliative care planning and provision. However, immigrant Chinese community remains a relatively marginalised and under-researched group in palliative care(3-5). This results in limited knowledge about its culture and people among health professionals, as well as the lack of experience in providing terminal care to Chinese immigrants. Through the introduction of New Zealand Palliative Care Strategy and the analysis of Chinese immigrants’ difficulties and preferences for palliative care, this aims to increase understanding of how cultural values of Chinese affect their acceptance and decision-making with respect to palliative care so that for efficiently providing palliative care to this ethnic minority group in New Zealand.
- 1 October 2021
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in Acta bioethica
- Vol. 27 (2) , 193-200
Open AccessPalliative care for Chinese immigrants in New Zealand: experiences and perceptions
Over the past several decades, palliative care has seen tremendous development in Western countries, but there is still inadequate access to palliative care among non-dominant ethnocultural groups. The Chinese have been the largest immigrant group in New Zealand since the 19th century(1). They have unique beliefs and practices around illness, death, dying and filial piety(2). These differ greatly from those in Western cultures and have notable implications for hospice palliative care planning and provision. However, immigrant Chinese community remains a relatively marginalised and under-researched group in palliative care(3-5). This results in limited knowledge about its culture and people among health professionals, as well as the lack of experience in providing terminal care to Chinese immigrants. Through the introduction of New Zealand Palliative Care Strategy and the analysis of Chinese immigrants’ difficulties and preferences for palliative care, this aims to increase understanding of how cultural values of Chinese affect their acceptance and decision-making with respect to palliative care so that for efficiently providing palliative care to this ethnic minority group in New Zealand.